Tag : ANNUAL BLEEDING RATE (ABR)

For individuals with hemophilia A, lifelong prophylactic treatment with FVIII replacement therapies or non-factor therapies (NFTs) is the standard of care. Despite advancements in treatment, bleeding episodes persist, significantly impacting physical health and quality of life (QoL).